Acura Pharmaceuticals Inc. (OTCMKTS:ACUR) Stock Jumps After Licensing Agreement

March 2, 2022

Acura Pharmaceuticals Inc. (OTCMKTS:ACUR) was up 9% after announcing the amendment of a licensed development and commercialization agreement with Abuse Deterrent Pharmaceuticals LLC regarding the LIMITx LTX-03 treatment candidate. Trading Data On Tuesday, ACUR stock surged 9% to $0.4680 with more than 12k shares traded, compared to its average volume of 8.6K shares. The stock moved within a range of $0.4375 – 0.4700 after opening trading at $0.44. Acura Pharmaceuticals…